Table 7.
Genes differentially expressed with EGFR inhibition but not differentially expressed in the glioblastoma versus astrocyte comparisona
| Genes | EGFRi LogFC | EGFRi FDR |
|---|---|---|
| Gm37694 | 2.64 | 8.85E−05 |
| Rhoq | −3.20 | 0.00017575 |
| Rrm1 | −1.63 | 0.00017575 |
| Mad2l1 | −2.26 | 0.00019026 |
| Mmp15 | −2.84 | 0.00019898 |
| Ncapg2 | −2.25 | 0.000263 |
| Miat | 3.99 | 0.00028567 |
| Ndrg2 | 2.25 | 0.00028567 |
| Hspa4 | −1.42 | 0.00028567 |
| Txn1 | −2.50 | 0.0002858 |
| Sfpq | −1.12 | 0.0002858 |
| Spred3 | −1.62 | 0.0002858 |
| Selenop | 1.50 | 0.00035539 |
| Mthfd2 | −4.40 | 0.00036567 |
| H2afx | −1.40 | 0.00036567 |
| Hip1 | −2.28 | 0.00036567 |
| Usp1 | −2.01 | 0.00037416 |
| Timeless | −1.99 | 0.00037709 |
| Lamp2 | 1.07 | 0.00037709 |
| Pole | −2.04 | 0.00041609 |
a
We used the following criteria: fold change >2 (Log fold change >1), FDR <0.01, and RPKM >1. We identified genes meeting all three criteria in EGFR inhibition versus control but not in the glioblastoma versus astrocyte comparison. We ranked genes by FDR and listed the top 20 genes.